Peer Review History

Original SubmissionJuly 19, 2019
Decision Letter - Ying-Mei Feng, Editor

PONE-D-19-20354

Cardio-metabolic abnormalities among patients with severe mental illness at a Regional Referral Hospital in southwestern Uganda

PLOS ONE

Dear Dr. Agaba,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

This manuscript describes the prevalence of abnormalities in cardio-metabolic risk factors among persons with a severe mental illness in southwestern Uganda. The manuscript shows a high level of abnormalities in SMI patients, which is alarming. I believe that the authors conducted a study that is very important for the organization of the mental health care situation in Uganda and that their data emphasizes the need for routine screening for cardio-metabolic abnormalities. I believe that the authors can significantly improve the paper by placing the outcomes as described in the paper in a wider context.

Major revisions

1.     The authors state that the aim of this study is to describe the cardio-metabolic abnormalities among patients with SMI attending the specific clinic at MRRH. However, after reading the introduction, it is unclear why the authors want to know these percentages; what do they want to do with these numbers? It is also unclear what the reference category is to which these numbers will be compared. Do the authors want to know the percentage of abnormalities in SMI patients as compared to the general population in Uganda, or as compared to SMI population in other countries? And why do the authors want to know this? The context of this study could be much more understandable if the authors explicitly state the underlying aim of why they want to know these percentages.

2.     For the reader, the procedure of including patients in the study is unclear. The manuscript does not provide any information about the procedure to inform patients about the study and to sign informed consent (should be described in the method section, and not as one line in the ethics section). It is also unclear how many patients were eligible (i.e. how many patients were invited to participate), and how many patients refused to sign informed consent (drop-out; should be described in the Results section). In addition, in the discussion, the authors mention the sample size calculation (line 236), which is not even described in the method section. This is all very important information that is now lacking in the manuscript.

3.     In the method section (line 86), the authors mention that they recruited a total of 304 patients. This is a result and should therefore be in the results section.

4.     The authors state that the fasting blood sugar levels were obtained after eight hours of fasting. Is it realistic that patients had been fasting for eight hours? Or could the percentage of persons with pre-diabetes or diabetes be influenced by non-fasting blood sugar levels?

5.     In the results section, the authors give number for ‘smokers’, ‘for ever taken alcohol’,  and for ‘physical activity’. It is unclear what questions were used to get these data; I believe this should be mentioned in the method section.

6.     Table 2: did the authors only include persons with the diagnosis ‘Schizophrenia’,  or were other psychotic diagnoses related to schizophrenia also included?

7.     Table 2: the variables mentioned in the table are not clear. ‘Antipsychotic’ is not bold, and as a reader I do not have a clue what the authors mean with this. Please clarify. Also, in Table 2, the use of the heading ‘Duration of psychotropic medication (yes)’, suggests that everyone uses psychotropic medication. After calculating the total numbers, is seems indeed that everyone is using medication. But, why are ‘antipsychotics’ framed as a separate variable and why are the types of medication for depression or bipolar disorder nog given? The order of the table and the missing information leaves the reader with questions, please adjust the table.

8.     Discussion: because for the reader, it is unclear why the authors would like to study these percentages (what the bigger aim is of knowing these numbers?), the discussion reads like a story summing up percentages without truly delivering a message. The percentages from the study are compared to percentages in either other SMI populations and to percentages in the general population of Uganda. I think the authors could truly improve the discussion by making clear what they want to do with these numbers, and to whom they want to compare these numbers, so that they can come up with a more in-depth discussion what could be done with these numbers. Now, the discussion only represents four paragraphs in which the numbers are compared to others, without drawing a conclusion. I think only two paragraphs should be spend on comparing these numbers, and thereafter, the authors should focus on the wider picture. Also, the phrase ‘unhealthy lifestyles’ pops up now and then, it is slightly touched, but I think the authors have more ideas about the role of unhealthy lifestyles and the early detection of cardio-metabolic abnormalities in solving the problem of these high cardio-metabolic abnormalities. 

9.     The conclusion summaries actually all that the reader wants to know more of in the introduction and the discussion. I think the conclusion has a very clear message of the why the authors want to know these numbers and what they aim to do after knowing these numbers. I think that the message of the conclusion should be highlighted more in the introduction (why do you want to know this) and in the discussion (now you know this, what can you do with1 his information).

Minor revisions

1.     Please be consistent in the use of the word cardio-metabolic (cardio-metabolic vs cardiometabolic).

2.     The sentence in the abstract from line 16 to 20 is unreadable, please rephrase.

3.     The author describes in line 46 to 50 the known percentages of cardio-metabolic abnormalities in SMI patients found in two previous meta-analyses. For the reader it’s unclear why the percentage of smokers is included in this summary, since this is a lifestyle behavior, not a cardio-metabolic abnormality. 

4.     The Introduction reads as one large paragraph. I believe that the use of more paragraphs would provide a better structure of the paper. The author could for example start a new paragraph from line 54. Also, the method section could use some paragraphs.

5.     In line 59, for the reader it’s unclear to what the word ‘they’ refers; it mostly reads as it refers to ‘lifestyle modification approaches’, but this is probably not what is meant. Please clarify in the text. 

6.     It is unclear what is meant with ‘acute symptoms with no insight’ (line 80). Please rephrase.

7.     The words ‘history of smoking’ are mentioned twice in the summary (line 90 and 91).

8.     When starting a new paragraph, it’s not preferable to start the first sentence with ‘These’  since the reader is unaware to what the word ‘these’ refers (line 112).

9.     Line 117: please do not use a capital for the word Triglycerides

10.     Please delete the word ‘obese’ in line 128, as it is redundant.

11.     In my opinion, the sentence about data collection (line 145) should be in de method section, not in the ethics section.

12.     In the tables, I believe it’s preferable to make the significant p-values bold, so it’s easier to scan the table.

13.     In the tables, I would prefer to see the mean ± standarddeviation not including ( ). 

14.     In Table 1, the Overall numbers for Single persons do miss a ) . I think the 0 should be deleted and replaced by a ), also to keep the number of decimals equal in the table. In Table 1, also, a space between ‘Female(N=169)’ is needed.

15.     The marital status ‘died’ is a bit odd; I think ‘widow(er)’ would be more appropriate.

16.     Please replace the ‘&’ with ‘and’ throughout the whole manuscript

17.     Please write numbers below ten as a word instead of a number, e.g., ‘3 psychiatrists’ should be ‘three psychiatrists’

18.     Please be consistent in the use of a space between the number and the percentage-sign throughout the whole manuscript (e.g. either 10% or 10 %).

19.     Describe square meters using the superscript function (i.e. m2)

20.     Line 192: it’s unclear where the word ‘that’ refers to, please clarify.

We would appreciate receiving your revised manuscript by Dec 07 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Ying-Mei Feng

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Revision 1

RESPONSE TO REVIEWER’S COMMENTS

Major revisions

1. The authors state that the aim of this study is to describe the cardio-metabolic abnormalities among patients with SMI attending the specific clinic at MRRH. However, after reading the introduction, it is unclear why the authors want to

know these percentages; what do they want to do with these numbers? It is also unclear what the reference category is to which these numbers will be compared. Do the authors want to know the percentage of abnormalities in SMI patients as compared to the general population in Uganda, or as compared to SMI population in other countries? And why do the authors want to know this? The context of this study could be much more understandable if the authors explicitly state the underlying aim of why they want to know these percentages.

Response: We have worked on the introduction to address this. We have added a paragraph that describes why we need to know the percentages of cardiometabolic abnormalities among patients with SMI. It reads “Although over 30% of Ugandans have some form of mental illness, there are no national or hospital-based screening guidelines for cardio-metabolic abnormalities among patients with SMI. Thus far, data on cardio-metabolic abnormalities among patients with SMI in Uganda are limited. The aim of this study was to describe the cardio-metabolic abnormalities among patients with SMI attending the outpatient mental health clinic at Mbarara Regional Referral Hospital (MRRH). Documenting the burden of cardio-metabolic abnormalities among patients with SMI is key, so as to inform policy makers to consider formulation of guidelines for screening of metabolic abnormalities. Routine and systematic cardiometabolic screening will enable initiation of appropriate management of cardio-metabolic abnormalities in a timely manner, in this patient population which will contribute towards improved quality of life. Moreover, there is epidemiological evidence to suggest that routine cardiometabolic screening could avert premature cardiometabolic disease among patients with SMI.” (line 65-77)

2. For the reader, the procedure of including patients in the study is unclear. The manuscript does not provide any information about the procedure to inform patients about the study and to sign informed consent (should be described

in the method section, and not as one line in the ethics section). It is also unclear how many patients were eligible (i.e. how many patients were invited to participate), and how many patients refused to sign informed consent (drop-out;

should be described in the Results section). In addition, in the discussion, the authors mention the sample size calculation (line 236), which is not even described in the method section. This is all very important information that is

now lacking in the manuscript.

Response:

The procedure for providing information about the study and to sign informed consent as well as details of sample size have been included: “We recruited participants consecutively as they came for review at the mental health clinic as long as they met the inclusion criteria until the sample size was obtained. The sample size of 304 was computed using the Kish Leslie formula of 1965 using 1.96 as the critical value at 5% level of significance, taking the prevalence of metabolic syndrome among patients with severe mental illness in sub-Saharan Africa to be 23.2%, based on a study from South Africa, 0.05 as a margin of error and adjusting for a non-response rate of 10%.

Participants who were eligible to participate in the study were given comprehensive information regarding the nature and purpose of the study and a consent document was read to them in the local language or english depending on the language they understood by a trained research assistant. They were given a chance to ask questions for clarity before they provided consent. Those who accepted to participate were given a consent form to sign.” (Line 100-111) Materials & Methods section

About the number of patients approached, those that declined or dropped out: A study flow chart has been included to address. Results section: line 186-198

A total of 385 participants were eligible but 81 were excluded (reasons listed in the flow chart) to remain with 304 who were recruited.

3. In the method section (line 86), the authors mention that they recruited a total of 304 patients. This is a result and should therefore be in the results section.

Response: This has been addressed. The statement has been corrected (line 100) and the number reported in results section.

4. The authors state that the fasting blood sugar levels were obtained after eight hours of fasting. Is it realistic that patients had been fasting for eight hours? Or could the percentage of persons with pre-diabetes or diabetes be influenced by non-fasting blood sugar levels?

Response: We made sure that all the participants had fasted for 8 hours. Those who had not fasted for the 8 hours were only included if they were willing to wait at the clinic till, they completed the 8 hours fast. This has been clarified in methods section. Line 147-148.

5. In the results section, the authors give number for ‘smokers’, ‘for ever taken alcohol’, and for ‘physical activity’. It is unclear what questions were used to get these data; I believe this should be mentioned in the method section.

Response: Thank you for this comment. We have improved this in the methods section under measurements (line 124-128)

6. Table 2: did the authors only include persons with the diagnosis ‘Schizophrenia’, or were other psychotic diagnoses related to schizophrenia also included?

Response: During participant recruitment, we only recruited participants with a confirmed diagnosis of schizophrenia and not other psychotic disorders since our inclusion criteria was SMI (bipolar, Major depression and schizophrenia)

7. Table 2: the variables mentioned in the table are not clear. ‘Antipsychotic’ is not bold, and as a reader I do not have a clue what the authors mean with this. Please clarify. Also, in Table 2, the use of the heading ‘Duration of

psychotropic medication (yes)’, suggests that everyone uses psychotropic medication. After calculating the total numbers, is seems indeed that everyone is using medication. But, why are ‘antipsychotics’ framed as a separate variable and why are the types of medication for depression or bipolar disorder not given? The order of the table and the missing information leaves the reader with questions, please adjust the table.

Response: Table 2 has been improved to bolden “antipsychotic” but has also been improved to “participants on antipsychotic medication”

It is true everyone was on psychotropic medication but not everyone was taking an antipsychotic medication. To our understanding, psychotropic medication includes antipsychotics, mood stabilizers and antidepressants. We give details of the class of antipsychotic medication and not for mood stabilizers or anti-depressants: This is informed by literature that shows differences in causation of cardiometabolic abnormalities among patients with SMI according to class of antipsychotic medication yet we don’t find any special considerations for mood stabilizers & antidepressants in literature.

8. Discussion: because for the reader, it is unclear why the authors would like to study these percentages (what the bigger aim is of knowing these numbers?), the discussion reads like a story summing up percentages without truly

delivering a message. The percentages from the study are compared to percentages in either other SMI populations and to percentages in the general population of Uganda. I think the authors could truly improve the discussion by

making clear what they want to do with these numbers, and to whom they want to compare these numbers, so that they can come up with a more in-depth discussion what could be done with these numbers. Now, the discussion only

represents four paragraphs in which the numbers are compared to others, without drawing a conclusion. I think only two paragraphs should be spend on comparing these numbers, and thereafter, the authors should focus on the wider

picture. Also, the phrase ‘unhealthy lifestyles’ pops up now and then, it is slightly touched, but I think the authors have more ideas about the role of unhealthy lifestyles and the early detection of cardio-metabolic abnormalities in solving the problem of these high cardio-metabolic abnormalities.

Response: Thank you for the guidance. We have tried to improve the discussion to make sense out of the numbers and we hope it reads better now.

For example:

I. “Our findings underscore the need for routine and systematic cardio-metabolic screening among patients with SMI in Uganda. Furthermore, there is need for interventions to address the high prevalence of obesity among patients with SMI. These interventions include: increase in physical activity, diet modification, careful selection of psychotropic medication for these patients based on their base-line laboratory findings; since some of the psychotropic medication such as atypical antipsychotic medication predispose patients to increased risk of obesity.” Line 252-259

II. “Overall, our findings demonstrate high prevalence of cardio-metabolic abnormalities among patients with SMI in southwestern Uganda. This emphasises the need for routine cardiometabolic screening strategies in this patient population. Furthermore, there is need to incorporate medical care services into mental health care, as well as designing local and national guidelines for screening and management of cardiometabolic abnormalities among patients with SMI.” Line 292-297

9. The conclusion summaries actually all that the reader wants to know more of in the introduction and the discussion. I think the conclusion has a very clear message of the why the authors want to know these numbers and what they aim to do after knowing these numbers. I think that the message of the conclusion should be highlighted more in the introduction (why do you want to know this) and in the discussion (now you know this, what can you do

With this information).

Response: Thank you for this comment and for your guidance on how best to improve our paper. The suggestions have been included in the introduction and discussion sections.

Minor revisions

1. Please be consistent in the use of the word cardio-metabolic (cardio-metabolic vs cardiometabolic).

Response: The word has been changed to cardio-metabolic across the entire document.

2. The sentence in the abstract from line 16 to 20 is unreadable, please rephrase.

Response: The sentence has been rephrased. Hope it reads better. “Although over 30% of Ugandans have some form of mental illness, there are no national or hospital-based screening guidelines for cardio-metabolic abnormalities among these patients, a general trend in most low-income countries. The screening rates for cardio-metabolic abnormalities in most low-income countries are at only 0.6%.” Line 17- 21

3. The author describes in line 46 to 50 the known percentages of cardio-metabolic abnormalities in SMI patients found in two previous meta-analyses. For the reader it’s unclear why the percentage of smokers is included in this

summary, since this is a lifestyle behaviour, not a cardio-metabolic abnormality.

Response: The statement has been improved. The percentage of smokers has been eliminated because it is not a cardio-metabolic abnormality. (Line 52-54)

4. The Introduction reads as one large paragraph. I believe that the use of more paragraphs would provide a better structure of the paper. The author could for example start a new paragraph from line 54. Also, the method section

could use some paragraphs.

Response: we have improved the sections by creating more paragraphs in the introduction and methods section.

5. In line 59, for the reader it’s unclear to what the word ‘they’ refers; it mostly reads as it refers to ‘lifestyle modification approaches’, but this is probably not what is meant. Please clarify in the text.

Response:

The statement has been improved to: “The low screening rates result in late diagnosis of these abnormalities at stages where lifestyle modification approaches are no longer very beneficial, thus leading to progression to cardiovascular disease.” Line 62-64

6. It is unclear what is meant with ‘acute symptoms with no insight’ (line 80). Please rephrase.

Response: The statement has been rephrased to “We excluded all patients who had acute symptoms of mental illness, those who had no insight and those considered unable to consent by the attending clinician” Line 95-97

7. The words ‘history of smoking’ are mentioned twice in the summary (line 90 and 91).

Response: This has been corrected. The repeated word has been deleted.

8. When starting a new paragraph, it’s not preferable to start the first sentence with ‘These’ since the reader is unaware to what the word ‘these’ refers (line 112).

Response: This has been corrected. (line 146)

9. Line 117: please do not use a capital for the word Triglycerides

Response: we have written the word properly as triglycerides (line 152)

10. Please delete the word ‘obese’ in line 128, as it is redundant.

Response: The word has been removed.

11. In my opinion, the sentence about data collection (line 145) should be in de method section, not in the ethics section.

Response: The sentence has been moved to methods section (Line 120-121)

12. In the tables, I believe it’s preferable to make the significant p-values bold, so it’s easier to scan the table.

Response: the significant p-values have been made bold in all tables.

13. In the tables, I would prefer to see the mean ± standard deviation not including ( ).

Response: This has been corrected in all tables and in the text.

14. In Table 1, the Overall numbers for Single persons do miss a ) . I think the 0 should be deleted and replaced by a), also to keep the number of decimals equal in the table. In Table 1, also, a space between ‘Female(N=169)’ is needed.

Response: Table 1 has been corrected as per the suggestions

15. The marital status ‘died’ is a bit odd; I think ‘widow(er)’ would be more appropriate.

Response: This has been corrected in table 1

16. Please replace the ‘&’ with ‘and’ throughout the whole manuscript

Response: The correction has been made all through the document.

17. Please write numbers below ten as a word instead of a number, e.g., ‘3 psychiatrists’ should be ‘three psychiatrists’

Response: the changes have been made all through the document. For example: line 84-86

18. Please be consistent in the use of a space between the number and the percentage-sign throughout the whole

manuscript (e.g. either 10% or 10 %).

Response: The change to use of no space has been effected all through the document

19. Describe square meters using the superscript function (i.e. m2)

Response: This has been corrected. Line: 151-153

20. Line 192: it’s unclear where the word ‘that’ refers to, please clarify

Response: This has been corrected to: “the prevalence of obesity” Line 242

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Ying-Mei Feng, Editor

Cardio-metabolic abnormalities among patients with severe mental illness at a Regional Referral Hospital in southwestern Uganda

PONE-D-19-20354R1

Dear Dr. Agaba,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ying-Mei Feng

Academic Editor

PLOS ONE

Formally Accepted
Acceptance Letter - Ying-Mei Feng, Editor

PONE-D-19-20354R1

Cardio-metabolic abnormalities among patients with severe mental illness at a Regional Referral Hospital in southwestern Uganda

Dear Dr. Agaba:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr Ying-Mei Feng

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .